EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,856 | -46.1% | 4,387 | -52.9% | 0.02% | -59.6% |
| Q2 2023 | $177,857 | -35.1% | 9,307 | -34.0% | 0.05% | -40.9% |
| Q1 2023 | $273,895 | -32.2% | 14,111 | -43.9% | 0.09% | -34.3% |
| Q4 2022 | $403,807 | +208.2% | 25,175 | +200.5% | 0.13% | +106.2% |
| Q3 2022 | $131,000 | +4.8% | 8,378 | +39.7% | 0.06% | -15.6% |
| Q2 2022 | $125,000 | +71.2% | 5,996 | +50.7% | 0.08% | +126.5% |
| Q4 2021 | $73,000 | -1.4% | 3,978 | +14.0% | 0.03% | -29.2% |
| Q3 2021 | $74,000 | – | 3,488 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |